Increased expression of PD-L1 on CLL B cells and PD-1 on CD4 + and CD8 + T cells results in attenuation of T cell activation, leading to T cell anergy and promoting the creation of an immunosuppressive microenvironment65–67. The gene discussed is PDCD1; the disease is B-cell chronic lymphocytic leukemia.